Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice

Experimental Neurology

Volumn 190, Issue 2, 2004, Pages 337-346

  Zaman, Vandana ^a,c   Nelson, Matthew E ^a   Gerhardt, Greg A ^b   Rohrer, Baerbel ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

BDNF; Dopamine; Dopaminergic system; Morphometry; Striatum; Substantia nigra; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; BRAIN MONOAMINE; DOPAMINE; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; NEUROTROPHIN;

ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL LOSS; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MORPHOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SUBSTANTIA NIGRA; WILD TYPE;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FRONTAL LOBE; HOMOVANILLIC ACID; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; NERVE DEGENERATION; NEURONS; RECEPTOR, TRKA; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 8644235230     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.08.002     Document Type: Article

References (67)

1. C.A. Altar, C.B. Boylan, C. Jackson, S. Hershenson, J. Miller, S.J. Wiegand, R.M. Lindsay, and C. Hyman Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo Proc. Natl. Acad. Sci. U. S. A. 89 1992 11347 11351
2. C.A. Altar, N. Cai, T. Bliven, M. Juhasz, J.M. Conner, A.L. Acheson, R.M. Lindsay, and S.J. Wiegand Anterograde transport of brain-derived neurotrophic factor and its role in the brain Nature 389 1997 856 860
3. K.D. Beck, B. Knusel, and F. Hefti The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture Neuroscience 52 1993 855 866
4. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
5. M. Bibel, and Y.A. Barde Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system Genes Dev. 14 2000 2919 2937
6. H.A. Bimonte, M.E. Nelson, and A.C. Granholm Age-related deficits as working memory load increases: relationships with growth factors Neurobiol. Aging 24 2003 37 48
7. A. Blochl, and C. Sirrenberg Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors J. Biol. Chem. 271 1996 21100 21107
8. J.M. Canals, S. Marco, N. Checa, A. Michels, E. Perez-Navarro, E. Arenas, and J. Alberch Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat model of Huntington's disease Neurobiol. Dis. 5 1998 357 364
9. J.M. Canals, N. Checa, S. Marco, P. Akerud, A. Michels, E. Perez-Navarro, E. Tolosa, E. Arenas, and J. Alberch Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area J. Neurosci. 21 2001 117 124
10. S. Ceccatelli, P. Ernfors, M.J. Villar, H. Persson, and T. Hokfelt Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment Proc. Natl. Acad. Sci. U. S. A. 88 1991 10352 10356
11. A. Cellerino, G. Pinzon-Duarte, P. Carroll, and K. Kohler Brain-derived neurotrophic factor modulates the development of the dopaminergic network in the rodent retina J. Neurosci. 18 1998 3351 3362
12. N.B. Chauhan, G.J. Siegel, and J.M. Lee Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain J. Chem. Neuroanat. 21 2001 277 288
13. D.E. Dluzen, G.M. Story, K. Xu, J. Kucera, and J.M. Walro Alterations in nigrostriatal dopaminergic function within BDNF mutant mice Exp. Neurol. 160 1999 500 507
14. D.E. Dluzen, X. Gao, G.M. Story, L.I. Anderson, J. Kucera, and J.M. Walro Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice Exp. Neurol. 170 2001 121 128
15. D.E. Dluzen, L.I. Anderson, J.L. McDermott, J. Kucera, and J.M. Walro Striatal dopamine output is compromised within +/-BDNF mice Synapse 43 2002 112 117
16. P.O. Fernagut, E. Diguet, B. Labattu, and F. Tison A simple method to measure stride length as an index of nigrostriatal dysfunction in mice J. Neurosci. Methods 113 2002 123 130
17. S. Finkbeiner, S.F. Tavazoie, A. Maloratsky, K.M. Jacobs, K.M. Harris, and M.E. Greenberg CREB: a major mediator of neuronal neurotrophin responses Neuron 19 1997 1031 1047
18. C.M. Fox, D.M. Gash, M.K. Smoot, and W.A. Cass Neuroprotective effects of GDNF against 6-OHDA in young and aged rats Brain Res. 896 2001 56 63
19. K.B.J. Franklin, and G. Paxinos The mouse brain in stereotaxic coordinates 1997 Academic Press New York
20. D.M. Frim, T.A. Uhler, W.R. Galpern, M.F. Beal, X.O. Breakefield, and O. Isacson Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat Proc. Natl. Acad. Sci. U. S. A. 91 1994 5104 5108
21. S.S. Gill, N.K. Patel, G.R. Hotton, K. O'Sullivan, R. McCarter, M. Bunnage, D.J. Brooks, C.N. Svendsen, and P. Heywood Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat. Med. 9 2003 589 595
22. A.C. Granholm, M. Reyland, D. Albeck, L. Sanders, G. Gerhardt, G. Hoernig, L. Shen, H. Westphal, and B. Hoffer Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons J. Neurosci. 20 2000 3182 3190
23. A.C. Granholm, K.A. Ford, L.A. Hyde, H.A. Bimonte, C.L. Hunter, M. Nelson, D. Albeck, L.A. Sanders, E.J. Mufson, and L.S. Crnic Estrogen restores cognition and cholinergic phenotype in an animal model of down syndrome Physiol. Behav. 77 2002 371 385
24. O. Guillin, N. Griffon, E. Bezard, L. Leriche, J. Diaz, C. Gross, and P. Sokoloff Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease Eur. J. Pharmacol. 480 2003 89 95
25. H.J. Gundersen, T.F. Bendtsen, L. Korbo, N. Marcussen, A. Moller, K. Nielsen, J.R. Nyengaard, B. Pakkenberg, F.B. Sorensen, and A. Vesterby Some new, simple and efficient stereological methods and their use in pathological research and diagnosis APMIS 96 1988 379 394
26. M.E. Hall, B.J. Hoffer, and G.A. Gerhardt Rapid and sensitive determination of catecholamines in small tissue samples by high pressure liquid chromatography coupled with dual-electrode coulometric electrochemical detection LC/GC 7 1989 258 265
27. G.U. Hoglinger, J. Feger, A. Prigent, P.P. Michel, K. Parain, P. Champy, M. Ruberg, W.H. Oertel, and E.C. Hirsch Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats J. Neurochem. 84 2003 491 502
28. D.W. Howells, M.J. Porritt, J.Y. Wong, P.E. Batchelor, R. Kalnins, A.J. Hughes, and G.A. Donnan Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra Exp. Neurol. 166 2000 127 135
29. M.M. Iravani, S. Costa, M.J. Jackson, B.C. Tel, C. Cannizzaro, R.K. Pearce, and P. Jenner GDNF reverses priming for dyskinesia in MPTP-treated, l-DOPA-primed common marmosets Eur. J. Neurosci. 13 2001 597 608
30. K.R. Jones, I. Farinas, C. Backus, and L.F. Reichardt Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development Cell 76 1994 989 999
31. C.M. Kearns, and D.M. Gash GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo Brain Res. 672 1995 104 111
32. Z. Kokaia, J. Bengzon, M. Metsis, M. Kokaia, H. Persson, and O. Lindvall Coexpression of neurotrophins and their receptors in neurons of the central nervous system Proc. Natl. Acad. Sci. U. S. A. 90 1993 6711 6715
33. Z. Kokaia, G. Andsberg, Q. Yan, and O. Lindvall Rapid alterations of BDNF protein levels in the rat brain after focal ischemia: evidence for increased synthesis and anterograde axonal transport Exp. Neurol. 154 1998 289 301
34. M. Levivier, S. Przedborski, C. Bencsics, and U.J. Kang Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease J. Neurosci. 15 1995 7810 7820
35. L.J. Lewis-Tuffin, P.G. Quinn, and D.M. Chikaraishi Tyrosine hydroxylase transcription depends primarily on cAMP response element activity, regardless of the type of inducing stimulus Mol. Cell Neurosci. 25 2004 536 547
36. A.K. McAllister, L.C. Katz, and D.C. Lo Neurotrophins and synaptic plasticity Annu. Rev. Neurosci. 22 1999 295 318
37. M. Mogi, A. Togari, T. Kondo, Y. Mizuno, O. Komure, S. Kuno, H. Ichinose, and T. Nagatsu Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease Neurosci. Lett. 270 1999 45 48
38. M. Morris, R. Iansek, T. Matyas, and J. Summers Abnormalities in the stride length-cadence relation in parkinsonian gait Mov. Disord. 13 1998 61 69
39. E.J. Mufson, J.S. Kroin, T. Sobreviela, M.A. Burke, J.H. Kordower, R.D. Penn, and J.A. Miller Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat Exp. Neurol. 129 1994 15 26
40. M. Neal, J. Cunningham, I. Lever, S. Pezet, and M. Malcangio Mechanism by which brain-derived neurotrophic factor increases dopamine release from the rabbit retina Invest. Ophthalmol. Visual Sci. 44 2003 791 798
41. S. Numan, and K.B. Seroogy Increased expression of trkB mRNA in rat caudate-putamen following 6-OHDA lesions of the nigrostriatal pathway Eur. J. Neurosci. 9 1997 489 495
42. K. Parain, M.G. Murer, Q. Yan, B. Faucheux, Y. Agid, E. Hirsch, and R. Raisman-Vozari Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra NeuroReport 10 1999 557 561
43. B. Rico, B. Xu, and L.F. Reichardt TrkB receptor signaling is required for establishment of GABAergic synapses in the cerebellum Nat. Neurosci. 5 2002 225 233
44. I. Rite, J.L. Venero, M. Tomas-Camardiel, A. Machado, and J. Cano Expression of BDNF mRNA in substantia nigra is dependent on target integrity and independent of neuronal activation J. Neurochem. 87 2003 709 721
45. N. Rocamora, E. Welker, M. Pascual, and E. Soriano Upregulation of BDNF mRNA expression in the barrel cortex of adult mice after sensory stimulation J. Neurosci. 16 1996 4411 4419
46. B. Rohrer, and J.M. Ogilvie Retarded outer segment development in TrkB knockout mouse retina organ culture Mol. Vision 9 2003 18 23
47. B. Rohrer, J.I. Korenbrot, M.M. LaVail, L.F. Reichardt, and B. Xu Role of neurotrophin receptor TrkB in the maturation of rod photoreceptors and establishment of synaptic transmission to the inner retina J. Neurosci. 19 1999 8919 8930
48. R. Schmidt-Kastner, C. Wetmore, and L. Olson Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular level suggests multiple roles in hippocampus, striatum and cortex Neuroscience 74 1996 161 183
49. K.B. Seroogy, K.H. Lundgren, T.M. Tran, K.M. Guthrie, P.J. Isackson, and C.M. Gall Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs J. Comp. Neurol. 342 1994 321 334
50. C.W. Shults, R.T. Matthews, C.A. Altar, L.R. Hill, and P.J. Langlais A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats Exp. Neurol. 125 1994 183 194
51. I. Stromberg, and P. Bickford Reduced ageing effects of striatal neuronal discharge rate by aged ventral mesencephalic grafts NeuroReport 7 1996 693 696
52. A.M. Sullivan, J. Opacka-Juffry, and S.B. Blunt Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo Eur. J. Neurosci. 10 1998 57 63
53. Y. Tillet Catecholaminergic neuronal systems in the diencephalon of mammals W.J.A.J. Smeets A. Reiner In phyologeny and development of catecholamine systems in the CNS of vertebrates 1994 Cambridge Univ. Press Cambridge 207 246
54. J.L. Venero, K.D. Beck, and F. Hefti 6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra NeuroReport 5 1994 429 432
55. J.L. Venero, M.L. Vizuete, M. Revuelta, C. Vargas, J. Cano, and A. Machado Upregulation of BDNF mRNA and trkB mRNA in the nigrostriatal system and in the lesion site following unilateral transection of the medial forebrain bundle Exp. Neurol. 161 2000 38 48
56. B.T. Volpe, J. Wildmann, and C.A. Altar Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions Neuroscience 83 1998 741 748
57. O. von Bohlen und Halbach, L. Minichiello, and K. Unsicker Haploinsufficiency in trkB and/or trkC neurotrophin receptors causes structural alterations in the aged hippocampus and amygdala Eur. J. Neurosci. 18 2003 2319 2325
58. G. Weskamp, and U. Otten An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues J. Neurochem. 48 1987 1779 1786
59. M.J. West New stereological methods for counting neurons Neurobiol. Aging 14 1993 275 285
60. G.L. Willis, and S.M. Armstrong Orphan neurones and amine excess: the functional neuropathology of parkinsonism and neuropsychiatric disease Brain Res., Brain Res. Rev. 27 1998 177 242
61. J.Y. Wong, G.T. Liberatore, G.A. Donnan, and D.W. Howells Expression of brain-derived neurotrophic factor and TrkB neurotrophin receptors after striatal injury in the mouse Exp. Neurol. 148 1997 83 91
62. B. Xu, W. Gottschalk, A. Chow, R.I. Wilson, E. Schnell, K. Zang, D. Wang, R.A. Nicoll, B. Lu, and L.F. Reichardt The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB J. Neurosci. 20 2000 6888 6897
63. Q. Yan, M.J. Radeke, C.R. Matheson, J. Talvenheimo, A.A. Welcher, and S.C. Feinstein Immunocytochemical localization of TrkB in the central nervous system of the adult rat J. Comp. Neurol. 378 1997 135 157
64. Q. Yan, R.D. Rosenfeld, C.R. Matheson, N. Hawkins, O.T. Lopez, L. Bennett, and A.A. Welcher Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system Neuroscience 78 1997 431 448
65. D.M. Yurek, and A. Fletcher-Turner Lesion-induced increase of BDNF is greater in the striatum of young versus old rat brain Exp. Neurol. 161 2000 392 396
66. D.M. Yurek, and A. Fletcher-Turner Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion Brain Res. 891 2001 228 235
67. V. Zaman, Z. Li, L. Middaugh, S. Ramamoorthy, B. Rohrer, M.E. Nelson, A.C. Tomac, B.J. Hoffer, G.A. Gerhardt, and A. Granholm The noradrenergic system of aged GDNF heterozygous mice Cell Transplant. 12 2003 291 303